Studie
|
Reden van exclusie
|
Asayama, K., Yamadera, H., Ito, T., Suzuki, H., Kudo, Y., & Endo, S. (2003). Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch, 70(4), 334–341.
|
Trial, niet met een specifieke indicatie angst.
|
Bachinskaya, N., Hoerr, R., & Ihl, R. (2011). Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial. Neuropsychiatr Dis Treat, 7, 209–215. http://doi.org/10.2147/ndt.s18741
|
Trial, niet met een specifieke indicatie angst.
|
Ballard, C., Margallo-Lana, M., Juszczak, E., Douglas, S., Swann, A., Thomas, A., … Jacoby, R. (2005). Quetiapine and rivastigmine and cognitive decline in Alzheimer’s disease: randomised double blind placebo controlled trial. BMJ (Clinical Research Ed.), 330(7496), 874. http://doi.org/10.1136/bmj.38369.459988.8F
|
Trial, niet met een specifieke indicatie angst.
|
Ballard, C., Thomas, A., Gerry, S., Yu, L. M., Aarsland, D., Merritt, C., … Walker, Z. (2015). A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer’s disease (MAIN-AD). J Am Med Dir Assoc, 16(4), 316–322. http://doi.org/10.1016/j.jamda.2014.11.002
|
Trial, niet placebo-gecontroleerd.
|
Boxer, A. L., Knopman, D. S., Kaufer, D. I., Grossman, M., Onyike, C., Graf-Radford, N., … Miller, B. L. (2013). Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol, 12(2), 149–156. http://doi.org/10.1016/s1474-4422(12)70320-4
|
Trial, niet met een specifieke indicatie angst.
|
Brodaty, H., Corey-Bloom, J., Potocnik, F. C. V, Truyen, L., Gold, M., & Damaraju, C. R. V. (2005). Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 20(2-3), 120–132. http://doi.org/10.1159/000086613
|
Trial, niet met een specifieke indicatie angst.
|
Cummings, J. L., McRae, T., & Zhang, R. (2006). Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatry, 14(7), 605–612. http://doi.org/10.1097/01.JGP.0000221293.91312.d3
|
Trial, niet met een specifieke indicatie angst.
|
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002). Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial. Lancet (London, England), 359(9314), 1283–1290. http://doi.org/10.1016/S0140-6736(02)08267-3
|
Trial, niet met een specifieke indicatie angst.
|
Gauthier, S., Feldman, H., Hecker, J., Vellas, B., Emir, B., & Subbiah, P. (2002). Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer’s disease. Current Medical Research and Opinion, 18(6), 347–354. http://doi.org/10.1185/030079902125001029
|
Trial, niet met een specifieke indicatie angst.
|
Gavrilova, S. I., Preuss, U. W., Wong, J. W. M., Hoerr, R., Kaschel, R., & Bachinskaya, N. (2014). Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial. International Journal of Geriatric Psychiatry, 29(10), 1087–1095. http://doi.org/10.1002/gps.4103
|
Trial, niet in een populatie met dementie.
|
Treatment of Parkinson’s disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment. (2011). Prescrire Int, 20(120), 242–245.
|
Meta-analyse, niet met een specifieke indicatie angst.
|
Gehrman, P. R., Connor, D. J., Martin, J. L., Shochat, T., Corey-Bloom, J., & Ancoli-Israel, S. (2009). Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry, 17(2), 166–169. http://doi.org/10.1097/JGP.0b013e318187de18
|
Trial, niet met een specifieke indicatie angst.
|
Herrschaft, H., Nacu, A., Likhachev, S., Sholomov, I., Hoerr, R., & Schlaefke, S. (2012). Ginkgo biloba extract EGb 761(R) in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J Psychiatr Res, 46(6), 716–723. http://doi.org/10.1016/j.jpsychires.2012.03.003
|
Trial, niet met een specifieke indicatie angst.
|
Holmes, C., Wilkinson, D., Dean, C., Vethanayagam, S., Olivieri, S., Langley, A., … Damms, J. (2004). The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology, 63(2), 214–219.
|
Stoptrial.
|
Ihl, R., Bachinskaya, N., Korczyn, A. D., Vakhapova, V., Tribanek, M., Hoerr, R., & Napryeyenko, O. (2011). Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Int J Geriatr Psychiatry, 26(11), 1186–1194. http://doi.org/10.1002/gps.2662
|
Trial, niet met een specifieke indicatie angst.
|
Ihl, R., Tribanek, M., & Bachinskaya, N. (2012). Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761(R) in Alzheimer’s disease and vascular dementia: results from a randomised controlled trial. Pharmacopsychiatry, 45(2), 41–46. http://doi.org/10.1055/s-0031-1291217
|
Trial, niet met een specifieke indicatie angst.
|
Jansen, S. L., Forbes, D. A., Duncan, V., & Morgan, D. G. (2006). Melatonin for cognitive impairment. Cochrane Database Syst Rev, (1), Cd003802. http://doi.org/10.1002/14651858.CD003802.pub3
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Jansen, S. L., Forbes, D., Duncan, V., Morgan, D. G., & Malouf, R. (2006). Melatonin for the treatment of dementia. Cochrane Database of Systematic Reviews, 3(4). http://doi.org/10.1002/14651858.CD003802.pub3
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Johannsen, P., Salmon, E., Hampel, H., Xu, Y., Richardson, S., Qvitzau, S., & Schindler, R. (2006). Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer’s disease. CNS Drugs, 20(4), 311–325.
|
Stoptrial.
|
Kavanagh, S., Gaudig, M., Van Baelen, B., Adami, M., Delgado, A., Guzman, C., … Schauble, B. (2011). Galantamine and behavior in Alzheimer disease: analysis of four trials. Acta Neurol Scand, 124(5), 302–308. http://doi.org/10.1111/j.1600-0404.2011.01525.x
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Kertesz, A., Morlog, D., Light, M., Blair, M., Davidson, W., Jesso, S., & Brashear, R. (2008). Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord, 25(2), 178–185. http://doi.org/10.1159/000113034
|
Stoptrial.
|
Krishnan, S., Cairns, R., & Howard, R. (2009). Cannabinoids for the treatment of dementia. Cochrane Database Syst Rev, (2), Cd007204. http://doi.org/10.1002/14651858.CD007204.pub2
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Lockhart, I. A. A., Orme, M. E. E., & Mitchell, S. A. A. (2011). The efficacy of licensed-indication use of donepezil and memantine monotherapies for treating behavioural and psychological symptoms of dementia in patients with Alzheimer’s disease: systematic review and meta-analysis. Dement Geriatr Cogn Dis Extra, 1(1), 212–227. http://doi.org/10.1159/000330032
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Mori, E., Ikeda, M., & Kosaka, K. (2012). Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol, 72(1), 41–52. http://doi.org/10.1002/ana.23557
|
Trial, niet met een specifieke indicatie angst.
|
Napryeyenko, O., & Borzenko, I. (2007). Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial. Arzneimittel-Forschung, 57(1), 4–11. http://doi.org/10.1055/s-0031-1296579
|
Trial, niet met een specifieke indicatie angst.
|
Nikolova G , Yancheva S , Raychev I, H. R. (2013). Ginkgo biloba extract in dementia: A 22-week randomised, placebo-controlled, double-blind trial . Bulgarian Neurology, 14, 139 – 143.
|
Trial, publicatie in Bulgaars.
|
Reisberg, B., Doody, R., Stoffler, A., Schmitt, F., Ferris, S., & Mobius, H. J. (2003). Memantine in moderate-to-severe Alzheimer’s disease. The New England Journal of Medicine, 348(14), 1333–1341. http://doi.org/10.1056/NEJMoa013128
|
Trial, niet met een specifieke indicatie angst.
|
Riemersma-van der Lek, R. F., Swaab, D. F., Twisk, J., Hol, E. M., Hoogendijk, W. J., & Van Someren, E. J. (2008). Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities. Jama, 299(22), 2642. http://doi.org/10.1001/jama.299.22.2642
|
Trial, niet met een specifieke indicatie angst.
|
Rockwood, K., Mintzer, J., Truyen, L., Wessel, T., & Wilkinson, D. (2001). Effects of a flexible galantamine dose in Alzheimer’s disease: a randomised, controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry, 71(5), 589–595.
|
Trial, niet met een specifieke indicatie angst.
|
Seitz, D. P., Gill, S. S., Herrmann, N., Brisbin, S., Rapoport, M. J., Rines, J., … Conn, D. K. (2013). Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. Int Psychogeriatr, 25(2), 185–203. http://doi.org/10.1017/s1041610212001627
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Serfaty, M., Kennell-Webb, S., Warner, J., Blizard, R., & Raven, P. (2002). Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry, 17(12), 1120–1127. http://doi.org/10.1002/gps.760
|
Trial, niet met een specifieke indicatie angst.
|
Singer, C., Tractenberg, R. E., Kaye, J., Schafer, K., Gamst, A., Grundman, M., … Thal, L. J. (2003). A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep, 26(7), 893–901.
|
Trial, niet met een specifieke indicatie angst.
|
Stinton, C., McKeith, I., Taylor, J. P., Lafortune, L., Mioshi, E., Mak, E., … O’Brien, J. T. (2015). Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis. Am J Psychiatry, 172(8), 731–742. http://doi.org/10.1176/appi.ajp.2015.14121582
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Tan, M. S., Yu, J. T., Tan, C. C., Wang, H. F., Meng, X. F., Wang, C., … Tan, L. (2015). Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis, 43(2), 589–603. http://doi.org/10.3233/jad-140837
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Tariot, P. N., Cummings, J. L., Katz, I. R., Mintzer, J., Perdomo, C. A., Schwam, E. M., & Whalen, E. (2001). A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer’s disease in the nursing home setting. Journal of the American Geriatrics Society, 49(12), 1590–1599.
|
Trial, niet met een specifieke indicatie angst.
|
van Dyck, C. H., Tariot, P. N., Meyers, B., & Malca Resnick, E. (2007). A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. Alzheimer Disease and Associated Disorders, 21(2), 136–143. http://doi.org/10.1097/WAD.0b013e318065c495
|
Trial, niet met een specifieke indicatie angst.
|
Vercelletto, M., Boutoleau-Bretonniere, C., Volteau, C., Puel, M., Auriacombe, S., Sarazin, M., … Lacomblez, L. (2011). Memantine in behavioral variant frontotemporal dementia: negative results. J Alzheimers Dis, 23(4), 749–759. http://doi.org/10.3233/jad-2010-101632
|
Trial, niet met een specifieke indicatie angst.
|
von Gunten, A., Schlaefke, S., & Uberla, K. (2015). Efficacy of Ginkgo biloba extract EGb 761 in dementia with behavioural and psychological symptoms: A systematic review. The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry, 1–12. http://doi.org/10.3109/15622975.2015.1066513
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Wang, J., Yu, J. T., Wang, H. F., Meng, X. F., Wang, C., Tan, C. C., & Tan, L. (2015). Pharmacological treatment of neuropsychiatric symptoms in Alzheimer’s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry, 86(1), 101–109. http://doi.org/10.1136/jnnp-2014-308112
|
Meta-analyse van trials zonder specifieke indicatie angst.
|
Wild, R., Pettit, T., Burns, A., R., W., T., P., & A., B. (2003). Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database Syst Rev, (3), Cd003672. http://doi.org/10.1002/14651858.cd003672
|
Meta-analyse, niet met een specifieke indicatie angst.
|
Winblad, B., Engedal, K., Soininen, H., Verhey, F., Waldemar, G., Wimo, A., … Subbiah, P. (2001). A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology, 57(3), 489–495.
|
Trial, niet met een specifieke indicatie angst.
|